At a glance
| Chemical family | Quaternary ammonium compound (QAC) — cationic surfactant and antimicrobial |
| CAS number | 8001-54-5 |
| Classification | Not IARC classified. Potent skin and eye irritant. Contact allergen (increasing prevalence). FDA excluded BAC from the consumer antiseptic wash rule (2016) — "not generally recognized as safe and effective" for that use but still widely permitted in other products |
| Where you encounter it | Disinfectant sprays and wipes (Lysol, Clorox); hand sanitizers; nasal sprays; eye drops; antimicrobial textile treatments; hospital disinfectants; food processing sanitizers |
| Sleep micro-environment relevance | Residue from disinfectant cleaning of bedroom surfaces; antimicrobial textile finishes on mattress protectors and pillowcases; hand-to-face transfer from hand sanitiser use before bed |
Regulatory & certification status
| European Union | Authorised under the Biocidal Products Regulation for several product types. REACH registered. CLP Acute Tox. 4 (H302), Skin Corr. 1B (H314), Aquatic Acute 1 / Chronic 1. Regulatory |
| United States | FDA excluded from consumer antiseptic wash rule (2016) — not GRAS/GRAE for that use. Still permitted in hand sanitizers (under separate monograph), disinfectants, and many other products. EPA registered as a disinfectant. Regulatory |
| Canada | Health Canada DIN registered for antimicrobial use. No restriction in consumer products. Regulatory |
| International | Not IARC classified. WHO does not set indoor air guidelines for BAC. Concerns about antimicrobial resistance promotion from widespread QAC use are growing in the scientific literature. Regulatory |
What it is
Benzalkonium chloride is a mixture of alkylbenzyldimethylammonium chlorides — cationic surfactants with antimicrobial properties. BAC disrupts microbial cell membranes, making it effective against bacteria, some viruses, fungi, and algae. It has been used commercially since the 1940s and is now one of the most ubiquitous antimicrobials in consumer products. IARC has not evaluated BAC for carcinogenicity. The toxicological concerns with BAC are primarily irritation and sensitisation: it is a well-documented skin and eye irritant, and contact allergy to BAC is increasingly recognised. In 2016, the FDA excluded BAC from its consumer antiseptic wash rule, determining it was not generally recognised as safe and effective for that specific use, though BAC remains permitted in many other product categories.
Where it shows up in bedding
BAC enters the bedroom through multiple everyday pathways. When disinfectant sprays or wipes containing BAC are used to clean nightstands, headboards, or bedroom surfaces, residues remain on those surfaces and can transfer to hands and then to bedding. Antimicrobial textile finishes on some mattress protectors, pillow covers, and sheets may contain BAC or related QACs. Hand sanitiser containing BAC applied before bed transfers residue to pillowcases through hand-to-face contact during sleep. For people with BAC sensitivity, these residues can contribute to facial dermatitis or eye irritation that appears during or after sleep.
Citations
- FDA (2016). Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use. Final Rule. Source Regulatory
- Kampf, G. (2018). Adaptive microbial response to low-level benzalkonium chloride exposure. Journal of Hospital Infection, 100(3): e1-e22. Source Peer-reviewed
- ECHA. Benzalkonium chloride — Substance Information. Source Regulatory
Frequently asked questions
Can disinfectant residue on my nightstand affect my sleep?
For most people, BAC residues from cleaning products on bedroom surfaces are not a concern. However, if you have BAC sensitivity or atopic dermatitis, residues on surfaces you touch (and then transfer to your face and pillowcase) could contribute to facial dermatitis or eye irritation. If you suspect this, switching to BAC-free cleaning products or rinsing surfaces after disinfecting can reduce exposure.
Does benzalkonium chloride promote antibiotic resistance?
There is growing concern in the scientific literature that widespread use of QACs like BAC at sub-lethal concentrations can promote antimicrobial resistance through cross-resistance mechanisms. Some bacteria exposed to low levels of BAC develop resistance to both BAC and clinical antibiotics. This is an active area of research and one reason regulatory agencies are scrutinizing BAC more closely.
Related compounds
Embr is a sleep environment company researching and addressing the chemistry of the bedroom. Research and product development in progress.
Last reviewed 2026-07-08. If you find a factual error, contact us.